<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Rheumatoid nodules</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Rheumatoid nodules</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Rheumatoid nodules</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John M Davis, MD, MS</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">James R O'Dell, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Philip Seo, MD, MHS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 03, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The rheumatoid nodule is the most common cutaneous manifestation of rheumatoid arthritis (RA) and is most often seen in patients with seropositive RA and more severe disease [<a href="#rid1">1-4</a>]. Although nodules are most commonly found on pressure points (such as the olecranon process), they may occur at other sites, including within the lung and other internal organs.</p><p>The accelerated formation of multiple rheumatoid nodules may also occur in association with certain medications, particularly <a class="drug drug_general" data-topicid="9630" href="/z/d/drug information/9630.html" rel="external">methotrexate</a>; the presence of multiple subcutaneous rheumatoid nodules can infrequently be seen with only mild or no systemic manifestations of RA, a condition termed rheumatoid nodulosis.</p><p>The clinical and histopathologic features, diagnosis, and management of rheumatoid nodules will be reviewed here. The articular features and an overview of the systemic and nonarticular manifestations of RA are presented separately. (See  <a class="medical medical_review" href="/z/d/html/7502.html" rel="external">"Clinical manifestations of rheumatoid arthritis"</a> and  <a class="medical medical_review" href="/z/d/html/7511.html" rel="external">"Overview of the systemic and nonarticular manifestations of rheumatoid arthritis"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Frequency of subcutaneous rheumatoid nodules</strong> – Palpable nodules in the subcutaneous tissues have been reported at initial presentation in 7 percent of patients with rheumatoid arthritis (RA) [<a href="#rid5">5</a>] and historically were found at some time during the disease course in 30 to 40 percent of patients [<a href="#rid6">6</a>]. In Rochester, Minnesota, the cumulative incidence of rheumatoid nodules declined substantially from 31 percent for patients diagnosed between 1985 and 1999 to 16 percent for patients diagnosed between 2000 and 2014, essentially halving the incidence of rheumatoid nodules [<a href="#rid7">7</a>]. This decline has paralleled epidemiological shifts in risk factors for extraarticular disease manifestations, tobacco smoking, and seropositive disease, as well as initiation of modern treatment strategies. Further research is needed to understand why rheumatoid nodules are declining in incidence and to determine if this is occurring globally in patients with RA.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Associated findings</strong> – In general, patients with rheumatoid nodules tend to have a severe RA phenotype, with more rapid progression of joint destruction than other patients with RA [<a href="#rid8">8</a>]. The vast majority of nodule-formers have positive tests for rheumatoid factor [<a href="#rid1">1</a>]; limited data suggest that many patients with rheumatoid nodules have positive tests for anti-citrullinated peptide antibodies (ACPA) [<a href="#rid9">9</a>].</p><p></p><p class="bulletIndent1">The presence of subcutaneous rheumatoid nodules is predictive of increased risk of cardiovascular disease as well as cardiovascular, respiratory, and all-cause mortality [<a href="#rid10">10,11</a>]. Patients with rheumatoid nodules are also at greater risk of hospitalization [<a href="#rid12">12</a>] due to complications of their disease or to comorbidities and to experience lower-extremity ulcers, which are associated with significant morbidity related to soft tissue, bone, and joint infections [<a href="#rid13">13</a>]. RA patients with nodules are also more likely to develop vasculitis [<a href="#rid14">14</a>]. Nodules are found in 75 percent of patients with RA-associated Felty syndrome [<a href="#rid15">15</a>]. (See  <a class="medical medical_review" href="/z/d/html/7482.html" rel="external">"Clinical manifestations and diagnosis of Felty syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pulmonary nodules</strong> – The prevalence of pulmonary rheumatoid nodules in patients with RA depends in part on the methods used for detection. As an example, plain radiographs of the chest revealed rheumatoid nodules in only 2 of 516 patients with RA in one clinical series [<a href="#rid16">16</a>]. However, a study of open lung biopsies from 40 patients with suspected lung disease found rheumatoid nodules in 13 subjects (32 percent); in 8 of 13 patients, there were multiple nodules [<a href="#rid17">17</a>]. Accelerated pulmonary nodulosis associated with <a class="drug drug_general" data-topicid="9630" href="/z/d/drug information/9630.html" rel="external">methotrexate</a> and other medications may also be seen. (See <a class="local">'Accelerated nodulosis'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nodules in other organs or tissues</strong> – Precise estimates of the prevalence and incidence of rheumatoid nodules in other organs or tissues are not available. The cumulative incidence of biopsy-confirmed rheumatoid nodules in the heart or elsewhere is reportedly &lt;1 percent [<a href="#rid18">18</a>]. The most frequent visceral sites beyond the lungs are the cardiac valves. A systematic review revealed a greater than 12-fold increased odds of valvular nodules in patients with RA compared with non-RA control subjects [<a href="#rid19">19</a>], and RA patients with subcutaneous nodules have an increased frequency of valvular involvement [<a href="#rid20">20</a>]. The occurrence of rheumatoid nodules in the central nervous system (eg, on the meninges) is very rare based on scattered case reports in the literature [<a href="#rid4">4</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Presence in disorders other than rheumatoid arthritis</strong> – Rheumatoid nodules have also been noted in occasional patients with systemic lupus erythematosus, ankylosing spondylitis, granuloma annulare (GA), and chronic active hepatitis and have been found infrequently in healthy children and adults [<a href="#rid15">15</a>].</p><p></p><p class="headingAnchor" id="H7"><span class="h1">PATHOLOGY AND PATHOGENESIS</span></p><p class="headingAnchor" id="H3834009292"><span class="h2">Histopathology</span><span class="headingEndMark"> — </span>The histologic appearance of a typical rheumatoid nodule includes a central area of necrosis surrounded in turn by palisading macrophages and then lymphocytes  (<a class="graphic graphic_picture graphicRef69272" href="/z/d/graphic/69272.html" rel="external">picture 1</a>) [<a href="#rid21">21-24</a>]. Histologic features of focal vasculitis with associated immunoglobulin (Ig), fibrin deposition, and complement activation can be found in one-third of all rheumatoid nodules [<a href="#rid15">15</a>].</p><p>Lymphoid aggregates containing B lymphocytes and features characteristic of lymphoid follicles have been reported in pulmonary nodules [<a href="#rid25">25</a>]. This contrasts with the expected structure of subcutaneous nodules, from which B cells and lymphoid follicles are normally absent. Such B cell aggregates may also occur in diffuse rheumatoid arthritis (RA)-associated interstitial lung disease, such as nonspecific interstitial pneumonitis or usual interstitial pneumonitis [<a href="#rid26">26</a>].</p><p class="headingAnchor" id="H855540020"><span class="h2">Pathogenesis</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cytokines, proteinases, and other immune factors</strong> – A variety of products, particularly cytokines and other immunoreactants, are produced within rheumatoid nodules, and the fibroblasts in the nodules produce large quantities of metalloproteases [<a href="#rid27">27</a>]. Most of the cytokine profile, together with the ability of the tissue to produce metalloproteinases, establishes the rheumatoid nodule as a T helper 1 (Th1) granuloma [<a href="#rid28">28-30</a>]. The lymphocytes can generate IgG and IgM rheumatoid factor.</p><p></p><p class="bulletIndent1">Examination for messenger ribonucleic acid (mRNA) transcripts for cytokines has revealed evidence for tumor necrosis factor (TNF) alpha, interferon gamma, interleukin (IL) 1 beta, IL-1 receptor antagonist, IL-10, IL-15, IL-18, and IL-12 (but not IL-2 or IL-4), as well as adhesion molecules E-selectin, intracellular adhesion molecule (ICAM) 1, platelet endothelial cell adhesion molecule (PECAM), and vascular cell adhesion molecule (VCAM). IL-17A is not found in rheumatoid nodules, in contrast to its presence in the rheumatoid synovial membrane [<a href="#rid31">31</a>]. Deposits of rheumatoid factor and the terminal components of complement are also found on the endothelium of small vessels within nodules [<a href="#rid32">32</a>].</p><p></p><p class="bulletIndent1">Peptidyl arginine deiminases 2, 3, and 4 and myeloperoxidase have been shown to generate citrullinated and homocitrullinated antigens in necrotic tissue of rheumatoid nodules [<a href="#rid33">33</a>]. Neutrophils express these enzymes, and through the generation of neutrophil extracellular traps (NETs), they may contribute to autoantigen externalization that may be targeted by anti-citrullinated peptide antibodies (ACPA), contributing to the inflammatory process within rheumatoid nodules [<a href="#rid34">34</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Immunogenetic factors</strong> – Human leukocyte antigen (HLA) alleles may be less important for development of nodules than for other extraarticular disease features. A meta-analysis of individual patient data from published studies showed no strong association between the presence of nodules and carriage of major histocompatibility complex (MHC) alleles (shared epitope) that are associated with RA, per se [<a href="#rid35">35</a>]. There was a weak association with only the HLADRbeta1*0401 shared epitope allele but not with other genotypes. This contrasts with a similar analysis of studies of RA-associated vasculitis, in which an association between vasculitis and a double dose of the shared epitope was found [<a href="#rid36">36</a>]. (See  <a class="medical medical_review" href="/z/d/html/7487.html" rel="external">"HLA and other susceptibility genes in rheumatoid arthritis"</a>.)</p><p></p><p class="bulletIndent1">In contrast to the weak association with HLA, IL-4 receptor (<em>IL4R</em>) single-nucleotide polymorphisms are associated with rheumatoid nodules [<a href="#rid37">37</a>]. In a sample of 749 patients in the Consortium for Longitudinal Evaluation of African Americans with Early Rheumatoid Arthritis (CLEAR) registry, the presence of <em>IL4R</em> single-nucleotide polymorphisms, either rs1801275 (odds ratio 8.1, 95% CI 1.6-40.9) or rs1805010 (odds ratio 2.74, 95% CI 0.80 to 9.41), was associated with the presence of rheumatoid nodules in patients with at least one HLA-DRB1 allele encoding the shared epitope [<a href="#rid37">37</a>]. The mechanism is unknown, but diminished responsiveness to IL-4 signaling could contribute to Th1-mediated inflammation. This association has not yet been replicated among African American individuals nor in other populations.</p><p></p><p class="bulletIndent1">A French study evaluated antibodies to the five immunodominant citrullinated epitopes within human fibrin (alpha-36-50cit, alpha-171-185cit, alpha-501-515cit, alpha-621-635cit, and beta-60-74) for association with HLA genotype and clinical phenotypes among 184 patients with ACPA-positive RA [<a href="#rid38">38</a>]. Anti-citrullinated fibrin alpha-501-515 antibodies in high titer were associated with rheumatoid nodules and correlated with HLA-DRB1*0401 and positive rheumatoid factor. The findings suggest a potential role for immune complexes containing anti-citrullinated fibrin alpha-501-515 antibodies and rheumatoid factor in the pathogenesis of rheumatoid nodules [<a href="#rid38">38</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Exogenous risk factors</strong> – Extrinsic risk factors, including drugs and cigarette smoking, appear to be implicated in some patients. A complication of <a class="drug drug_general" data-topicid="9630" href="/z/d/drug information/9630.html" rel="external">methotrexate</a> therapy in some patients with RA is the increased formation of rheumatoid nodules, a proinflammatory effect that occurs even when synovial inflammation is suppressed [<a href="#rid39">39,40</a>] (see <a class="local">'Accelerated nodulosis'</a> below). Among susceptible individuals, this complication may be due to the activation of adenosine A1 receptors by methotrexate, which leads to enhanced cellular fusion and the formation of multinucleated giant cells [<a href="#rid41">41</a>]. It is unknown if activation of adenosine pathways is involved in nodulosis associated with other medications.</p><p></p><p class="bulletIndent1">Cigarette smoking may increase the risk of developing rheumatoid nodules. This was illustrated in a study of 1589 patients with early RA in which those with nodules were compared with age- and sex-matched RA controls [<a href="#rid5">5</a>]. Those with nodules were significantly more likely to have ever smoked cigarettes (odds ratio 7.3, 95% CI 2.3-24.6). Smoking is also associated with vasculitis [<a href="#rid42">42,43</a>] and other severe extraarticular manifestations of RA [<a href="#rid18">18,44</a>].</p><p></p><p class="headingAnchor" id="H2970620989"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H1336725322"><span class="h2">Subcutaneous nodules</span><span class="headingEndMark"> — </span>Subcutaneous nodules are the most common form of rheumatoid nodule and are most commonly found on pressure points or areas of repeated trauma, such as the olecranon process and other extensor areas (eg, on the hands and fingers), but occur at other sites as well. The size of the nodules varies from 2 mm to 5 cm; they are firm, nontender, and may either be moveable in subcutaneous tissue or bound down to underlying fascia or periosteum  (<a class="graphic graphic_picture graphicRef74194" href="/z/d/graphic/74194.html" rel="external">picture 2</a>) [<a href="#rid15">15</a>]. Nodules are more common in patients with severe rheumatoid arthritis (RA); bedridden patients can develop nodules on the occiput and ischial areas, and nodules occasionally form on tendons and ligamentous tissues, such as the Achilles tendon and vocal cords [<a href="#rid45">45</a>].</p><p>In many cases, the nodules are neither symptomatic nor a cosmetic concern. However, rheumatoid nodules can be painful and/or disfiguring, interfere with function, or cause compressive neuropathies. Some patients find the nodules more distressing than the arthritis. The nodules may also ulcerate and thus serve as a site for local infection or other distant infectious complications by hematogenous spread of bacteria.</p><p class="headingAnchor" id="H2088265616"><span class="h2">Pulmonary nodules</span><span class="headingEndMark"> — </span>Nodules in the lungs in RA are generally located in subpleural areas or in association with interlobular septa [<a href="#rid46">46</a>]. Pulmonary rheumatoid nodules are generally asymptomatic but can lead to complications, including pleural effusion, pneumothorax, pyopneumothorax, bronchopleural fistula, or hemoptysis.</p><p>Consistent with their histopathologic features, which can differ from subcutaneous nodules in that they may contain B lymphocytes and features of lymphoid follicles (see <a class="local">'Histopathology'</a> above), reduction in size or even disappearance of pulmonary rheumatoid nodules may sometimes be seen in patients with severe RA treated with the B-cell-depleting agent <a class="drug drug_general" data-topicid="9616" href="/z/d/drug information/9616.html" rel="external">rituximab</a> [<a href="#rid47">47</a>].</p><p>Rheumatoid nodules in the lungs, their complications, and rheumatoid nodules associated with pneumoconiosis (Caplan syndrome) are discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/4380.html" rel="external">"Overview of pleuropulmonary diseases associated with rheumatoid arthritis", section on 'Rheumatoid lung nodules'</a>.)</p><p class="headingAnchor" id="H4136895723"><span class="h2">Cardiac nodules</span><span class="headingEndMark"> — </span>Rheumatoid nodules may develop in the pericardium, myocardium, and valvular structures [<a href="#rid48">48</a>]. The presence of subcutaneous nodules is associated with valvular thickening, nodules, and insufficiency, mainly of the mitral and aortic values on echocardiography [<a href="#rid20">20</a>]. Symptoms related to the presence of nodules are rare, but syncope or death due to heart block from a lesion situated in the conduction system can occur [<a href="#rid49">49</a>]. Stroke or other manifestations of arterial embolization may result from nodules on a heart valve [<a href="#rid50">50-52</a>].</p><p class="headingAnchor" id="H3043539751"><span class="h2">Other noncutaneous sites</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Central nervous system</strong> – Rheumatoid nodules may rarely affect the central nervous system. This is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/7480.html" rel="external">"Neurologic manifestations of rheumatoid arthritis", section on 'Rheumatoid nodules'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other organs</strong> – Rheumatoid nodules have also been described in case reports to rarely occur in other organs and tissues, including the oral mucosa and the lip [<a href="#rid53">53,54</a>], thyroid gland [<a href="#rid55">55</a>], lymph nodes [<a href="#rid56">56</a>], liver [<a href="#rid57">57-59</a>], and kidneys [<a href="#rid57">57,60</a>].</p><p></p><p class="headingAnchor" id="H2345119707"><span class="h2">Accelerated nodulosis</span><span class="headingEndMark"> — </span>A poorly understood phenomenon is that some patients treated for RA with <a class="drug drug_general" data-topicid="9630" href="/z/d/drug information/9630.html" rel="external">methotrexate</a> have a noticeable increase in the size and number of rheumatoid nodules. This is referred to as accelerated nodulosis. Typically, patients with this condition rapidly develop numerous small subcutaneous nodules primarily over the fingers, hands, or wrists, though other sites have been described, such as elbows, scalp, Achilles tendon, larynx, and lungs [<a href="#rid61">61,62</a>]. Nodulosis has also occasionally been associated in RA patients with treatment with <a class="drug drug_general" data-topicid="9026" href="/z/d/drug information/9026.html" rel="external">azathioprine</a>, <a class="drug drug_general" data-topicid="8925" href="/z/d/drug information/8925.html" rel="external">etanercept</a>, <a class="drug drug_general" data-topicid="10097" href="/z/d/drug information/10097.html" rel="external">leflunomide</a> [<a href="#rid15">15</a>], and <a class="drug drug_general" data-topicid="10208" href="/z/d/drug information/10208.html" rel="external">tocilizumab</a> [<a href="#rid63">63</a>].</p><p>The onset of methotrexate-induced accelerated nodulosis has been described as early as one month and as long as eight years after the initiation of <a class="drug drug_general" data-topicid="9630" href="/z/d/drug information/9630.html" rel="external">methotrexate</a> therapy [<a href="#rid61">61,62</a>]. Nodules associated with methotrexate therapy are otherwise similar in their morphology and clinical manifestations to usual RA nodules.</p><p>Exploratory analyses has suggested that patients with polymorphisms in the methylenetetrahydrofolate reductase (<em>MTHFR</em>) and adenosine A2a receptor (<em>ADORA2A</em>) genes may have an increased frequency of methotrexate-induced nodulosis, supporting potential causal roles for the folate and adenosine pathways in the pathogenesis of nodulosis [<a href="#rid64">64</a>].</p><p>Accelerated pulmonary nodulosis has been reported to follow <a class="drug drug_general" data-topicid="9630" href="/z/d/drug information/9630.html" rel="external">methotrexate</a>, anti-tumor necrosis factor (TNF) therapy, and <a class="drug drug_general" data-topicid="10097" href="/z/d/drug information/10097.html" rel="external">leflunomide</a> treatment [<a href="#rid65">65-68</a>]. These can mimic infection or malignancy.</p><p class="headingAnchor" id="H1917823414"><span class="h2">Rheumatoid nodulosis</span><span class="headingEndMark"> — </span>Rheumatoid nodulosis is the term used for a variant of polyarthritis associated with features of palindromic rheumatism, radiologic subchondral bone cysts, and subcutaneous rheumatoid nodules [<a href="#rid69">69,70</a>]. Patients typically exhibit multiple subcutaneous nodules, particularly on the hands, and multiple subchondral bone cysts known as "geodes" [<a href="#rid71">71</a>]. The nodules tend to occur on extensor surfaces adjacent to joints, elbows, and fingers, and can affect the forearm, metacarpophalangeal and proximal interphalangeal joints, occiput, back, heel, and other areas [<a href="#rid15">15</a>]. Many of the affected patients have minimal clinical and radiographic joint disease without chronic synovitis, but a minority may go on to develop chronic, erosive RA [<a href="#rid70">70</a>].</p><p class="headingAnchor" id="H8"><span class="h1">DIAGNOSIS</span></p><p class="headingAnchor" id="H1247154629"><span class="h2">Subcutaneous nodules</span><span class="headingEndMark"> — </span>In a patient with rheumatoid arthritis (RA), a slowly developing, firm, painless, subcutaneous nodule located at a pressure point is almost certainly a rheumatoid nodule. These can be movable or bound down to underlying fascia or periosteum. Thus, in patients with typical asymptomatic subcutaneous nodules, further evaluation is usually not required to establish the diagnosis. However, a biopsy is indicated in patients with unusual or complicated presentations. As examples, patients with nodules that exhibit progressive rapid growth, unusual location, ulceration, or a suspected alternative diagnosis such as infection or malignancy should undergo surgical excision of the entire nodule.</p><p>The finding of a nodule with characteristic histologic findings on biopsy is nearly pathognomonic for RA and rheumatoid nodules (see <a class="local">'Histopathology'</a> above). However, nodules with a similar histologic appearance rarely occur in some patients with systemic lupus erythematosus and in otherwise healthy children [<a href="#rid72">72-76</a>].</p><p class="headingAnchor" id="H106781589"><span class="h2">Pulmonary nodules</span><span class="headingEndMark"> — </span>Rheumatoid nodules in the lung parenchyma are more difficult to diagnose with confidence than subcutaneous nodules, but the radiologic features are helpful in making the diagnosis. Computed tomography (CT) is usually necessary for further evaluation of pulmonary infiltrates or nodules identified on a screening chest radiograph. Typical findings on CT imaging include the presence of multiple nodules, smooth borders, satellite nodules, cavitation, and peripheral or subpleural location, occasionally with an associated subpleural rind of confluent soft tissue [<a href="#rid77">77</a>]. A biopsy is often required to confirm the diagnosis and to exclude malignancy, infection, or other abnormalities. (See <a class="local">'Differential diagnosis'</a> below.)</p><p>As an example, a rheumatoid nodule in the lung may not be definitively diagnosed until lung cancer has been excluded by biopsy or excision. The evaluation of solitary and multiple pulmonary nodules is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4380.html" rel="external">"Overview of pleuropulmonary diseases associated with rheumatoid arthritis", section on 'Rheumatoid lung nodules'</a> and  <a class="medical medical_review" href="/z/d/html/6986.html" rel="external">"Diagnostic evaluation of the incidental pulmonary nodule"</a>.)</p><p class="headingAnchor" id="H9"><span class="h1">DIFFERENTIAL DIAGNOSIS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Subcutaneous nodules</strong> – Numerous conditions can be associated with nodules or cysts that may potentially resemble rheumatoid nodules, depending upon their anatomic location and consistency. However, the concurrent presence of active rheumatoid arthritis (RA) with positive rheumatoid factor or anti-citrullinated peptide antibodies (ACPA) together with distribution over extensor surfaces and other pressure points strongly suggests rheumatoid nodules, and the distinction can usually be made clinically without further testing. When a biopsy is required, the distinction between rheumatoid and other nodules can usually be made based upon the histologic findings.</p><p></p><p class="bulletIndent1">The differential diagnosis for the most common causes of subcutaneous nodules includes fibromas caused by chronic trauma from shoes or repetitive use of hand tools, subcutaneous granuloma annulare (GA), gouty tophi, and calcinosis [<a href="#rid1">1,15</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Subcutaneous granuloma annulare</strong> – Subcutaneous GA, also known as "pseudorheumatoid nodules," can be seen in adults but are more common in children. These are typically &lt;4 cm in diameter, single or multiple, and most commonly located on the scalp, hands, anterior tibia, or feet (see  <a class="medical medical_review" href="/z/d/html/13705.html" rel="external">"Granuloma annulare: Epidemiology, clinical manifestations, and diagnosis"</a>). Histopathologic features may resemble rheumatoid nodules, including a lymphohistiocytic infiltrate, often in an interstitial or palisaded pattern, but the presence of mucin deposition is suggestive of GA [<a href="#rid78">78</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Gouty tophi</strong> – Gouty tophi should be suspected in a patient with a history of acute mono- or oligoarticular arthritis, most commonly involving the great toe metatarsophalangeal (MTP) joints or other lower extremity joints; hyperuricemia; and the physical appearance of tophi, which is often characteristic, with a white to yellow coloration of the subcutaneous monosodium urate deposits (see  <a class="medical medical_review" href="/z/d/html/1667.html" rel="external">"Clinical manifestations and diagnosis of gout"</a>). The diagnosis can be confirmed when necessary by aspiration and polarized microscopy showing needle-shaped, negatively birefringent crystals.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Calcinosis cutis</strong> – Calcinosis cutis refers to dystrophic calcification at sites of microtrauma or inflammation, which typically occurs in patients with systemic sclerosis, dermatomyositis, or overlap connective tissue diseases (see  <a class="medical medical_review" href="/z/d/html/13756.html" rel="external">"Calcinosis cutis: Etiology and patient evaluation"</a>). These lesions are composed of calcium hydroxyapatite and typically manifest as multiple subcutaneous papules or nodules that are yellow-white in the hands, elbows, or feet but may also occur in soft tissues of the trunk or legs. Calcinosis lesions may ulcerate and exude chalky white material. These nodules may be evident on plain radiography.</p><p></p><p>Rare mimickers of rheumatoid nodules include epithelioid sarcoma, infectious granuloma, necrobiosis lipoidica diabeticorum, and tumoral calcinosis [<a href="#rid79">79</a>]. In patients in whom the diagnosis is uncertain, referral to a medical dermatologist for further evaluation may be warranted.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lung nodule(s)</strong> – The most important diagnosis to exclude in a patient with RA and a pulmonary nodule is non-small cell lung cancer at a potentially curable stage. Features on chest CT that suggest malignancy rather than rheumatoid nodules include solitary nodules, spiculated borders, central location, and presence of air bronchograms in the region [<a href="#rid77">77</a>]. On positron emission tomography (PET) imaging, malignant nodules present with substantially higher fluorodeoxyglucose (FDG) avidity than rheumatoid nodules, and malignant nodules are associated with FDG-avid draining lymph nodes whereas rheumatoid nodules are not [<a href="#rid77">77</a>].</p><p></p><p class="bulletIndent1">Accelerated pulmonary nodulosis that follows <a class="drug drug_general" data-topicid="9630" href="/z/d/drug information/9630.html" rel="external">methotrexate</a>, anti-tumor necrosis factor (TNF) therapy, and <a class="drug drug_general" data-topicid="10097" href="/z/d/drug information/10097.html" rel="external">leflunomide</a> treatment can mimic infection or malignancy [<a href="#rid65">65-68</a>].</p><p></p><p class="bulletIndent1">Additional investigations are usually required to establish the diagnosis in patients in whom radiographic stability of a solitary lesion cannot be demonstrated conclusively by review of prior chest radiographs or if prior studies are unavailable; the evaluation may include continued observation with serial imaging studies, biopsy of the lesion, or surgical excision. The approach to a patient with RA and an asymptomatic pulmonary nodule is similar to that for others with solitary nodules and is described in detail separately, as are the causes of multiple pulmonary nodules and their evaluation. (See  <a class="medical medical_review" href="/z/d/html/6986.html" rel="external">"Diagnostic evaluation of the incidental pulmonary nodule"</a>.)</p><p></p><p class="headingAnchor" id="H12"><span class="h1">MANAGEMENT</span></p><p class="headingAnchor" id="H3152385793"><span class="h2">General approach</span><span class="headingEndMark"> — </span>Treatment decisions depend upon several factors, including:</p><p class="bulletIndent1"><span class="glyph">●</span>The potential role of <a class="drug drug_general" data-topicid="9630" href="/z/d/drug information/9630.html" rel="external">methotrexate</a> as a cause of accelerated nodulosis</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The presence or absence of symptoms, including pain, nerve compression, infection, mechanical dysfunction, or other complications</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Response to initial therapeutic interventions</p><p></p><p class="headingAnchor" id="H13"><span class="h2">Methotrexate-induced accelerated nodulosis</span><span class="headingEndMark"> — </span>For patients with symptomatic accelerated nodulosis associated with <a class="drug drug_general" data-topicid="9630" href="/z/d/drug information/9630.html" rel="external">methotrexate</a> treatment, and for whom there are reasonable alternative treatments, we suggest the discontinuation of methotrexate and a change to an alternative synthetic or biologic disease-modifying antirheumatic drug (DMARD). The decision whether to switch therapies in patients whose articular disease activity is well controlled and whose nodulosis is only a cosmetic concern is based upon patient preferences regarding the relative risks and benefits of switching to one of the available alternative DMARD therapies, route and frequency of administration, and cost concerns. (See  <a class="medical medical_review" href="/z/d/html/7477.html" rel="external">"Alternatives to methotrexate for the initial treatment of rheumatoid arthritis in adults"</a> and  <a class="medical medical_review" href="/z/d/html/7490.html" rel="external">"Treatment of rheumatoid arthritis in adults resistant to initial conventional synthetic (nonbiologic) DMARD therapy"</a>.)</p><p>Nodules commonly require 6 months (range, 1 to 13 months) to regress after discontinuation of <a class="drug drug_general" data-topicid="9630" href="/z/d/drug information/9630.html" rel="external">methotrexate</a> [<a href="#rid62">62</a>]. In a review of several case series and multiple case reports, approximately 70 percent of cases of accelerated nodulosis resolved with stopping the methotrexate [<a href="#rid61">61</a>]. Nodules that are symptomatic or impinging upon local structures and causing dysfunction should be approached and treated as described for typical rheumatoid nodules. (See <a class="local">'Initial therapy'</a> below.)</p><p>Regression of nodules has also been noted in case series and reports of patients who received various other nonbiologic DMARDs or <a class="drug drug_general" data-topicid="9293" href="/z/d/drug information/9293.html" rel="external">colchicine</a> [<a href="#rid61">61</a>]. Subsequent case reports suggested that <a class="drug drug_general" data-topicid="9616" href="/z/d/drug information/9616.html" rel="external">rituximab</a> may be effective treatment for some cases of severe subcutaneous nodulosis [<a href="#rid80">80</a>], and rituximab, <a class="drug drug_general" data-topicid="10208" href="/z/d/drug information/10208.html" rel="external">tocilizumab</a>, and <a class="drug drug_general" data-topicid="118052" href="/z/d/drug information/118052.html" rel="external">baricitinib</a> could cause regression of pulmonary rheumatoid nodules [<a href="#rid81">81-84</a>]. The author prefers to switch to interleukin (IL) 6 receptor antagonists or rituximab in cases of persistent nodules with moderate or high disease activity.</p><p class="headingAnchor" id="H14"><span class="h2">Subcutaneous nodules without accelerated nodulosis</span></p><p class="headingAnchor" id="H98379676"><span class="h3">Initial therapy</span><span class="headingEndMark"> — </span>For patients with symptomatic subcutaneous nodules, including those that are painful, interfere with function, or cause nerve entrapment, we suggest local injection of the nodule with a mix of glucocorticoids and a local anesthetic as the initial treatment. Asymptomatic nodules require no specific treatment. A long-acting glucocorticoid (eg, 0.1 to 0.3 mL of <a class="drug drug_general" data-topicid="9639" href="/z/d/drug information/9639.html" rel="external">methylprednisolone</a> or <a class="drug drug_general" data-topicid="10015" href="/z/d/drug information/10015.html" rel="external">triamcinolone</a> hexacetonide 40 mg/mL) and local anesthetic (eg, 1 percent <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a>) in a 1:1 mixture by volume are typically used for injection. (See  <a class="medical medical_review" href="/z/d/html/7985.html" rel="external">"Intraarticular and soft tissue injections: What agent(s) to inject and how frequently?"</a>.)</p><p>Local injection is contraindicated for nodules that are ulcerated or exhibit signs of localized infection or cellulitis. Caution should be exercised prior to injecting a nodule in patients with a history of severe skin or soft tissue infections or septic arthritis or for nodules overlying prosthetic joints.</p><p>Local glucocorticoid injection of rheumatoid nodules is often effective in decreasing their size. This was illustrated in a study of 24 nodules in 11 patients with rheumatoid arthritis (RA). Patients were randomly assigned for each injection to receive either <a class="drug drug_general" data-topicid="9639" href="/z/d/drug information/9639.html" rel="external">methylprednisolone</a> or placebo, and assessment was blinded [<a href="#rid85">85</a>]. A &gt;50 percent loss in nodule volume occurred in a greater proportion of those who received glucocorticoid injections (9 of 12 versus 1 of 12). Similar benefits were subsequently reported in a randomized trial involving 20 patients with symptomatic nodules (one nodule each), which employed <a class="drug drug_general" data-topicid="10015" href="/z/d/drug information/10015.html" rel="external">triamcinolone</a> hexacetonide and <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> for injection, compared with lidocaine alone [<a href="#rid86">86</a>]. The only adverse effect in either trial was pain at the injection site. Nodules typically regress in size over one to three weeks.</p><p class="headingAnchor" id="H3487876056"><span class="h3">Resistant to initial therapy or nodules causing serious complications</span><span class="headingEndMark"> — </span>Nodules that are causing serious complications and in symptomatic patients who have not responded after four to six weeks to local injection should generally be surgically excised. Indications for early surgical treatment of rheumatoid nodules, rather than trying a local injection, include skin erosion and infection, severe pain or neurologic dysfunction arising from pressure on a peripheral nerve, and marked limitation of motion because of the location of the lesion [<a href="#rid76">76</a>]. Recurrence of nodules at the same site is frequently seen.</p><p class="headingAnchor" id="H3947329776"><span class="h2">Visceral nodules</span><span class="headingEndMark"> — </span>Surgical resection of pulmonary nodules is sometimes indicated for diagnostic purposes and is also sometimes performed because of related complications from the nodule(s). Surgical or intravascular approaches to cardiac nodules should be undertaken only when there is firm evidence that the nodules are contributing to abnormal cardiac function, rhythm disturbances, or embolic events.</p><p class="headingAnchor" id="H2049094779"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>Patients with rheumatoid nodules may have a worse prognosis of their rheumatoid arthritis (RA) articular and extraarticular manifestations than patients without nodules, given the association with more severe and seropositive disease and other extraarticular complications (see <a class="local">'Epidemiology'</a> above). However, RA nodules may not have independent predictive value for radiographic progression at five years following diagnosis after accounting for anti-citrullinated peptide antibodies (ACPA) and radiographic damage at diagnosis [<a href="#rid8">8</a>].</p><p>Symptoms and complications associated with subcutaneous nodules can usually be addressed effectively by appropriate treatment interventions, although recurrence is common despite surgical excision (see <a class="local">'Management'</a> above). Among 11 patients, surgical excision of rheumatoid nodules was successful in 100 percent, and significant improvements in pain, stiffness, and physical function, along with high patient satisfaction, were reported [<a href="#rid87">87</a>]. Rarely, visceral nodules, particularly those in the lung and heart, and even less often in the central nervous system, may directly cause significant morbidity.</p><p class="headingAnchor" id="H17"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – Rheumatoid nodules are a common extraarticular manifestation of rheumatoid arthritis (RA). Historically, subcutaneous nodules have occurred at some time in 30 to 40 percent of patients, but limited evidence suggests that the incidence is declining over the past two decades. Patients with rheumatoid nodules tend to have a greater incidence of severe disease phenotypes, including propensity for joint destruction, development of other extraarticular manifestations, and increased cardiovascular, pulmonary, and all-cause mortality. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathology</strong> – Wherever rheumatoid nodules are found, they have a similar histologic appearance. Characteristic features include a central area of necrosis surrounded by concentric layers of palisading macrophages and lymphocytes. As is the case for the synovitis of RA, the pathogenesis is uncertain but involves multiple components of innate and adaptive immunity. (See <a class="local">'Pathology and pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnosis of subcutaneous lesions can be made from their proximity to pressure points, generally intact overlying skin, and firm to hard nature on palpation, often with fixation to the underlying periosteum. Although the histopathologic features are nearly pathognomonic, biopsy is rarely necessary for diagnosis of rheumatoid nodules located in or beneath the skin. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pulmonary nodules</strong> – In patients found to have an asymptomatic single lung nodule, we perform a thorough evaluation to exclude a potentially resectable lung cancer. An approach to diagnosis in this setting is discussed in more detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/6986.html" rel="external">"Diagnostic evaluation of the incidental pulmonary nodule"</a> and <a class="local">'Pulmonary nodules'</a> above.)</p><p></p><p class="bulletIndent1">The presence of multiple pulmonary nodules requires thorough evaluation to exclude treatable infectious and potentially curable neoplastic diseases. The differential diagnosis and evaluation of such patients is presented separately. (See  <a class="medical medical_review" href="/z/d/html/6986.html" rel="external">"Diagnostic evaluation of the incidental pulmonary nodule"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cardiac nodules</strong> – Rheumatoid nodules in the myocardium can cause heart block; lesions located on or near the heart valves may cause regurgitation or embolic events. (See <a class="local">'Cardiac nodules'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – For symptomatic nodules, we suggest local injection of glucocorticoids and a local anesthetic as the initial treatment (<a class="grade" href="https:///uptodate/show/grade_5" rel="external">Grade 2B</a>). For an asymptomatic subcutaneous nodule, therapy targeted to treating the nodule is not necessary. (See <a class="local">'General approach'</a> above and <a class="local">'Subcutaneous nodules without accelerated nodulosis'</a> above.)</p><p></p><p class="bulletIndent1">A complication of <a class="drug drug_general" data-topicid="9630" href="/z/d/drug information/9630.html" rel="external">methotrexate</a> therapy in some patients with RA is the increased formation of rheumatoid nodules. In patients for whom there are reasonable alternative treatments, we suggest discontinuation of methotrexate and a change to an alternative targeted synthetic or biologic disease-modifying antirheumatic drug (DMARD) (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). Patients whose articular disease activity is well controlled and whose nodulosis is only a cosmetic concern may choose to continue methotrexate therapy. (See <a class="local">'Methotrexate-induced accelerated nodulosis'</a> above.)</p><p></p><p class="bulletIndent1">For patients with symptomatic subcutaneous nodules that have resulted in complications (eg, skin ulceration, nerve compression) and that either are not appropriate for glucocorticoid injection or have not responded to local injection, surgical excision may be necessary. (See <a class="local">'Resistant to initial therapy or nodules causing serious complications'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Sayah A, English JC 3rd. Rheumatoid arthritis: a review of the cutaneous manifestations. J Am Acad Dermatol 2005; 53:191.</a></li><li><a class="nounderline abstract_t">Highton J, Hessian PA, Stamp L. The Rheumatoid nodule: peripheral or central to rheumatoid arthritis? Rheumatology (Oxford) 2007; 46:1385.</a></li><li><a class="nounderline abstract_t">Chua-Aguilera CJ, Möller B, Yawalkar N. Skin Manifestations of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritides. Clin Rev Allergy Immunol 2017; 53:371.</a></li><li><a class="nounderline abstract_t">Tilstra JS, Lienesch DW. Rheumatoid Nodules. Dermatol Clin 2015; 33:361.</a></li><li><a class="nounderline abstract_t">Nyhäll-Wåhlin BM, Jacobsson LT, Petersson IF, et al. Smoking is a strong risk factor for rheumatoid nodules in early rheumatoid arthritis. Ann Rheum Dis 2006; 65:601.</a></li><li><a class="nounderline abstract_t">Turesson C, Jacobsson LT. Epidemiology of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol 2004; 33:65.</a></li><li><a class="nounderline abstract_t">Kimbrough BA, Crowson CS, Davis JM 3rd, et al. Decline in Incidence of Extra-Articular Manifestations of Rheumatoid Arthritis: A Population-Based Cohort Study. Arthritis Care Res (Hoboken) 2023.</a></li><li><a class="nounderline abstract_t">Nyhäll-Wåhlin BM, Turesson C, Jacobsson LT, et al. The presence of rheumatoid nodules at early rheumatoid arthritis diagnosis is a sign of extra-articular disease and predicts radiographic progression of joint destruction over 5 years. Scand J Rheumatol 2011; 40:81.</a></li><li><a class="nounderline abstract_t">Kim SK, Park SH, Shin IH, Choe JY. Anti-cyclic citrullinated peptide antibody, smoking, alcohol consumption, and disease duration as risk factors for extraarticular manifestations in Korean patients with rheumatoid arthritis. J Rheumatol 2008; 35:995.</a></li><li><a class="nounderline abstract_t">Kaushik P, Solomon DH, Greenberg JD, et al. Subcutaneous nodules are associated with cardiovascular events in patients with rheumatoid arthritis: results from a large US registry. Clin Rheumatol 2015; 34:1697.</a></li><li><a class="nounderline abstract_t">England BR, Sayles H, Michaud K, et al. Cause-Specific Mortality in Male US Veterans With Rheumatoid Arthritis. Arthritis Care Res (Hoboken) 2016; 68:36.</a></li><li><a class="nounderline abstract_t">Michet CJ 3rd, Strobova K, Achenbach S, et al. Hospitalization rates and utilization among patients with rheumatoid arthritis: a population-based study from 1987 to 2012 in Olmsted County, Minnesota. Mayo Clin Proc 2015; 90:176.</a></li><li><a class="nounderline abstract_t">Jebakumar AJ, Udayakumar PD, Crowson CS, et al. Occurrence and effect of lower extremity ulcer in rheumatoid arthritis -- a population-based Study. J Rheumatol 2014; 41:437.</a></li><li><a class="nounderline abstract_t">Turesson C, McClelland RL, Christianson T, Matteson E. Clustering of extraarticular manifestations in patients with rheumatoid arthritis. J Rheumatol 2008; 35:179.</a></li><li><a class="nounderline abstract_t">García-Patos V. Rheumatoid nodule. Semin Cutan Med Surg 2007; 26:100.</a></li><li><a class="nounderline abstract_t">Walker WC, Wright V. Pulmonary lesions and rheumatoid arthritis. Medicine (Baltimore) 1968; 47:501.</a></li><li><a class="nounderline abstract_t">Yousem SA, Colby TV, Carrington CB. Lung biopsy in rheumatoid arthritis. Am Rev Respir Dis 1985; 131:770.</a></li><li><a class="nounderline abstract_t">Turesson C, O'Fallon WM, Crowson CS, et al. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 2003; 62:722.</a></li><li><a class="nounderline abstract_t">Corrao S, Messina S, Pistone G, et al. Heart involvement in rheumatoid arthritis: systematic review and meta-analysis. Int J Cardiol 2013; 167:2031.</a></li><li><a class="nounderline abstract_t">Wisłowska M, Sypuła S, Kowalik I. Echocardiographic findings and 24-h electrocardiographic Holter monitoring in patients with nodular and non-nodular rheumatoid arthritis. Rheumatol Int 1999; 18:163.</a></li><li><a class="nounderline abstract_t">Palmer DG, Hogg N, Highton J, et al. Macrophage migration and maturation within rheumatoid nodules. Arthritis Rheum 1987; 30:728.</a></li><li><a class="nounderline abstract_t">Athanasou NA, Quinn J, Woods CG, Mcgee JO. Immunohistology of rheumatoid nodules and rheumatoid synovium. Ann Rheum Dis 1988; 47:398.</a></li><li><a class="nounderline abstract_t">Miyasaka N, Sato K, Yamamoto K, et al. Immunological and immunohistochemical analysis of rheumatoid nodules. Ann Rheum Dis 1989; 48:220.</a></li><li><a class="nounderline abstract_t">Wikaningrum R, Highton J, Parker A, et al. Pathogenic mechanisms in the rheumatoid nodule: comparison of proinflammatory cytokine production and cell adhesion molecule expression in rheumatoid nodules and synovial membranes from the same patient. Arthritis Rheum 1998; 41:1783.</a></li><li><a class="nounderline abstract_t">Highton J, Hung N, Hessian P, Wilsher M. Pulmonary rheumatoid nodules demonstrating features usually associated with rheumatoid synovial membrane. Rheumatology (Oxford) 2007; 46:811.</a></li><li><a class="nounderline abstract_t">Atkins SR, Turesson C, Myers JL, et al. Morphologic and quantitative assessment of CD20+ B cell infiltrates in rheumatoid arthritis-associated nonspecific interstitial pneumonia and usual interstitial pneumonia. Arthritis Rheum 2006; 54:635.</a></li><li><a class="nounderline abstract_t">Harris ED Jr. A collagenolytic system produced by primary cultures of rheumatoid nodule tissue. J Clin Invest 1972; 51:2973.</a></li><li><a class="nounderline abstract_t">Hessian PA, Highton J, Kean A, et al. Cytokine profile of the rheumatoid nodule suggests that it is a Th1 granuloma. Arthritis Rheum 2003; 48:334.</a></li><li><a class="nounderline abstract_t">Edwards JC, Wilkinson LS, Pitsillides AA. Palisading cells of rheumatoid nodules: comparison with synovial intimal cells. Ann Rheum Dis 1993; 52:801.</a></li><li><a class="nounderline abstract_t">Elewaut D, De Keyser F, De Wever N, et al. A comparative phenotypical analysis of rheumatoid nodules and rheumatoid synovium with special reference to adhesion molecules and activation markers. Ann Rheum Dis 1998; 57:480.</a></li><li><a class="nounderline abstract_t">Stamp LK, Easson A, Lehnigk U, et al. Different T cell subsets in the nodule and synovial membrane: absence of interleukin-17A in rheumatoid nodules. Arthritis Rheum 2008; 58:1601.</a></li><li><a class="nounderline abstract_t">Kato H, Yamakawa M, Ogino T. Complement mediated vascular endothelial injury in rheumatoid nodules: a histopathological and immunohistochemical study. J Rheumatol 2000; 27:1839.</a></li><li><a class="nounderline abstract_t">Turunen S, Huhtakangas J, Nousiainen T, et al. Rheumatoid arthritis antigens homocitrulline and citrulline are generated by local myeloperoxidase and peptidyl arginine deiminases 2, 3 and 4 in rheumatoid nodule and synovial tissue. Arthritis Res Ther 2016; 18:239.</a></li><li><a class="nounderline abstract_t">Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med 2013; 5:178ra40.</a></li><li><a class="nounderline abstract_t">Gorman JD, David-Vaudey E, Pai M, et al. Lack of association of the HLA-DRB1 shared epitope with rheumatoid nodules: an individual patient data meta-analysis of 3,272 Caucasian patients with rheumatoid arthritis. Arthritis Rheum 2004; 50:753.</a></li><li><a class="nounderline abstract_t">Gorman JD, David-Vaudey E, Pai M, et al. Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis. Arthritis Rheum 2004; 50:3476.</a></li><li><a class="nounderline abstract_t">Burgos PI, Causey ZL, Tamhane A, et al. Association of IL4R single-nucleotide polymorphisms with rheumatoid nodules in African Americans with rheumatoid arthritis. Arthritis Res Ther 2010; 12:R75.</a></li><li><a class="nounderline abstract_t">Larid G, Pancarte M, Offer G, et al. In Rheumatoid Arthritis Patients, HLA-DRB1*04:01 and Rheumatoid Nodules Are Associated With ACPA to a Particular Fibrin Epitope. Front Immunol 2021; 12:692041.</a></li><li><a class="nounderline abstract_t">Cronstein BN, Eberle MA, Gruber HE, Levin RI. Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci U S A 1991; 88:2441.</a></li><li><a class="nounderline abstract_t">Kremer JM, Lee JK. The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. Arthritis Rheum 1986; 29:822.</a></li><li><a class="nounderline abstract_t">Merrill JT, Shen C, Schreibman D, et al. Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritis. Arthritis Rheum 1997; 40:1308.</a></li><li><a class="nounderline abstract_t">Struthers GR, Scott DL, Delamere JP, et al. Smoking and rheumatoid vasculitis. Rheumatol Int 1981; 1:145.</a></li><li><a class="nounderline abstract_t">Turesson C, Schaid DJ, Weyand CM, et al. Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis. Arthritis Rheum 2006; 54:2776.</a></li><li><a class="nounderline abstract_t">Nyhäll-Wåhlin BM, Petersson IF, Nilsson JA, et al. High disease activity disability burden and smoking predict severe extra-articular manifestations in early rheumatoid arthritis. Rheumatology (Oxford) 2009; 48:416.</a></li><li><a class="nounderline abstract_t">Ylitalo R, Heimbürger M, Lindestad PA. Vocal fold deposits in autoimmune disease--an unusual cause of hoarseness. Clin Otolaryngol Allied Sci 2003; 28:446.</a></li><li><a class="nounderline abstract_t">Walters MN, Ojeda VJ. Pleuropulmonary necrobiotic rheumatoid nodules. A review and clinicopathological study of six patients. Med J Aust 1986; 144:648.</a></li><li><a class="nounderline abstract_t">Glace B, Gottenberg JE, Mariette X, et al. Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: findings in 10 patients from the French AutoImmunity and Rituximab/Rheumatoid Arthritis registry (AIR/PR registry). Ann Rheum Dis 2012; 71:1429.</a></li><li><a class="nounderline abstract_t">Kitas G, Banks MJ, Bacon PA. Cardiac involvement in rheumatoid disease. Clin Med (Lond) 2001; 1:18.</a></li><li><a class="nounderline abstract_t">Ahern M, Lever JV, Cosh J. Complete heart block in rheumatoid arthritis. Ann Rheum Dis 1983; 42:389.</a></li><li><a class="nounderline abstract_t">Chatzis A, Giannopoulos N, Baharakakis S, et al. Unusual cause of a stroke in a patient with seronegative rheumatoid arthritis. Cardiovasc Surg 1999; 7:659.</a></li><li><a class="nounderline abstract_t">Mounet FS, Soula P, Concina P, Cerene A. A rare case of embolizing cardiac tumor: rheumatoid nodule of the mitral valve. J Heart Valve Dis 1997; 6:77.</a></li><li><a class="nounderline abstract_t">Kang H, Baron M. Embolic complications of a mitral valve rheumatoid nodule. J Rheumatol 2004; 31:1001.</a></li><li><a class="nounderline abstract_t">Kato K, Segami N, Fukuda H, Minato H. Rheumatoid nodule in the lower lip of a patient with rheumatoid arthritis: a novel case report and review of literature. J Oral Maxillofac Surg 2014; 72:1532.e1.</a></li><li><a class="nounderline abstract_t">Tay GC, Sauer DA, Andersen PE. Rheumatoid nodule presenting as a buccal submucosal nodule: A rare presentation of a common disease. Head Neck 2017; 39:E12.</a></li><li><a class="nounderline abstract_t">Sivridis E, Kouroupi M, Koukourakis MI, et al. Rheumatoid nodules in thyroid gland parenchyma as an expression of rheumatoid arthritis: a case report. J Med Case Rep 2019; 13:159.</a></li><li><a class="nounderline abstract_t">Yachoui R, Ward C, Kreidy M. A rheumatoid nodule in an unusual location: mediastinal lymph node. BMJ Case Rep 2013; 2013.</a></li><li><a class="nounderline abstract_t">Tiong VTY, Ng SJK, Hallinan JTPD. Multiple Rheumatoid Nodules Mimicking Widespread Metastases. J Clin Rheumatol 2020; 26:e256.</a></li><li><a class="nounderline abstract_t">Smits JG, Kooijman CD. Rheumatoid nodules in liver. Histopathology 1986; 10:1211.</a></li><li><a class="nounderline abstract_t">Campani C, Guido M, Colagrande S, et al. A Large Rheumatoid Nodule Mimicking Hepatic Malignancy. Hepatology 2019; 69:1345.</a></li><li><a class="nounderline abstract_t">Schned AR, Moran M, Selikowitz SM, Taylor TH. Multiple rheumatoid nodules of the renal cortex. Arch Intern Med 1990; 150:891.</a></li><li><a class="nounderline abstract_t">Patatanian E, Thompson DF. A review of methotrexate-induced accelerated nodulosis. Pharmacotherapy 2002; 22:1157.</a></li><li><a class="nounderline abstract_t">Ahmed SS, Arnett FC, Smith CA, et al. The HLA-DRB1*0401 allele and the development of methotrexate-induced accelerated rheumatoid nodulosis: a follow-up study of 79 Caucasian patients with rheumatoid arthritis. Medicine (Baltimore) 2001; 80:271.</a></li><li><a class="nounderline abstract_t">Talotta R, Atzeni F, Batticciotto A, et al. Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series. J Med Case Rep 2018; 12:154.</a></li><li><a class="nounderline abstract_t">Soukup T, Dosedel M, Nekvindova J, et al. The plausible association of MTHFR and ADORA2A polymorphisms with nodules in rheumatoid arthritis patients treated with methotrexate. Pharmacogenet Genomics 2017; 27:43.</a></li><li><a class="nounderline abstract_t">Watson P, Simler N, Screaton N, Lillicrap M. Management of accelerated pulmonary nodulosis following etanercept therapy in a patient with rheumatoid arthritis. Rheumatology (Oxford) 2008; 47:928.</a></li><li><a class="nounderline abstract_t">Horvath IF, Szanto A, Csiki Z, et al. Intrapulmonary rheumatoid nodules in a patient with long-standing rheumatoid arthritis treated with leflunomide. Pathol Oncol Res 2008; 14:101.</a></li><li><a class="nounderline abstract_t">Rozin A, Yigla M, Guralnik L, et al. Rheumatoid lung nodulosis and osteopathy associated with leflunomide therapy. Clin Rheumatol 2006; 25:384.</a></li><li><a class="nounderline abstract_t">Akiyama N, Toyoshima M, Kono M, et al. Methotrexate-induced Accelerated Pulmonary Nodulosis. Am J Respir Crit Care Med 2015; 192:252.</a></li><li><a class="nounderline abstract_t">Couret M, Combe B, Chuong VT, et al. Rheumatoid nodulosis: report of two new cases and discussion of diagnostic criteria. J Rheumatol 1988; 15:1427.</a></li><li><a class="nounderline abstract_t">Maldonado I, Eid H, Rodriguez GR, et al. Rheumatoid nodulosis: is it a different subset of rheumatoid arthritis? J Clin Rheumatol 2003; 9:296.</a></li><li><a class="nounderline abstract_t">Ginsberg MH, Genant HK, Yü TF, McCarty DJ. Rheumatoid nodulosis: an unusual variant of rheumatoid disease. Arthritis Rheum 1975; 18:49.</a></li><li><a class="nounderline abstract_t">Schofield JK, Cerio R, Grice K. Systemic lupus erythematosus presenting with 'rheumatoid nodules'. Clin Exp Dermatol 1992; 17:53.</a></li><li><a class="nounderline abstract_t">Hassikou H, Le Guilchard F, Lespessailles E, et al. Rheumatoid nodules in systemic lupus erythematosus: a case report. Joint Bone Spine 2003; 70:234.</a></li><li><a class="nounderline abstract_t">Simons FE, Schaller JG. Benign rheumatoid nodules. Pediatrics 1975; 56:29.</a></li><li><a class="nounderline abstract_t">Mastboom WJ, van der Staak FH, Festen C, Postma MH. Subcutaneous rheumatoid nodules. Arch Dis Child 1988; 63:662.</a></li><li><a class="nounderline abstract_t">McGrath MH, Fleischer A. The subcutaneous rheumatoid nodule. Hand Clin 1989; 5:127.</a></li><li><a class="nounderline abstract_t">Koslow M, Young JR, Yi ES, et al. Rheumatoid pulmonary nodules: clinical and imaging features compared with malignancy. Eur Radiol 2019; 29:1684.</a></li><li><a class="nounderline abstract_t">Sturm B, Blaise B, Wilson M, Stone SP. Pseudorheumatoid nodule: a variant of granuloma annulare? Dermatol Online J 2020; 26.</a></li><li><a class="nounderline abstract_t">Fareez F, Moodley J, Popovic S, Lu JQ. Rheumatoid nodules: a narrative review of histopathological progression and diagnostic consideration. Clin Rheumatol 2023; 42:1753.</a></li><li><a class="nounderline abstract_t">Sautner J, Rintelen B, Leeb BF. Rituximab as effective treatment in a case of severe subcutaneous nodulosis in rheumatoid arthritis. Rheumatology (Oxford) 2013; 52:1535.</a></li><li><a class="nounderline abstract_t">De Stefano R, Frati E, Nargi F, Menza L. Efficacy of rituximab on pulmonary nodulosis occurring or increasing in patients with rheumatoid arthritis during anti-TNF-α therapy. Clin Exp Rheumatol 2011; 29:752.</a></li><li><a class="nounderline abstract_t">Andres M, Vela P, Romera C. Marked improvement of lung rheumatoid nodules after treatment with tocilizumab. Rheumatology (Oxford) 2012; 51:1132.</a></li><li><a class="nounderline abstract_t">Venerito V, Lopalco G, Anelli MG, et al. Tomographic regression of pulmonary rheumatoid nodules under baricitinib therapy. Rheumatology (Oxford) 2019; 58:440.</a></li><li><a class="nounderline abstract_t">Liu H, Li Q, Long K, et al. Rheumatoid arthritis with pulmonary accelerated rheumatoid nodules treated by baricitinib: a case-based review. Clin Rheumatol 2023.</a></li><li><a class="nounderline abstract_t">Ching DW, Petrie JP, Klemp P, Jones JG. Injection therapy of superficial rheumatoid nodules. Br J Rheumatol 1992; 31:775.</a></li><li><a class="nounderline abstract_t">Baan H, Haagsma CJ, van de Laar MA. Corticosteroid injections reduce size of rheumatoid nodules. Clin Rheumatol 2006; 25:21.</a></li><li><a class="nounderline abstract_t">Riches PL, Elherik FK, Dolan S, et al. Patient rated outcomes study into the surgical interventions available for the rheumatoid hand and wrist. Arch Orthop Trauma Surg 2016; 136:563.</a></li></ol></div><div id="topicVersionRevision">Topic 7523 Version 25.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16021111" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Rheumatoid arthritis: a review of the cutaneous manifestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17623747" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The Rheumatoid nodule: peripheral or central to rheumatoid arthritis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28752373" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Skin Manifestations of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritides.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26143419" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Rheumatoid Nodules.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16166104" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Smoking is a strong risk factor for rheumatoid nodules in early rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15163106" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Epidemiology of extra-articular manifestations in rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37691141" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Decline in Incidence of Extra-Articular Manifestations of Rheumatoid Arthritis: A Population-Based Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20919947" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : The presence of rheumatoid nodules at early rheumatoid arthritis diagnosis is a sign of extra-articular disease and predicts radiographic progression of joint destruction over 5 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18464311" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Anti-cyclic citrullinated peptide antibody, smoking, alcohol consumption, and disease duration as risk factors for extraarticular manifestations in Korean patients with rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26242470" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Subcutaneous nodules are associated with cardiovascular events in patients with rheumatoid arthritis: results from a large US registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26097231" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Cause-Specific Mortality in Male US Veterans With Rheumatoid Arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25659235" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Hospitalization rates and utilization among patients with rheumatoid arthritis: a population-based study from 1987 to 2012 in Olmsted County, Minnesota.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24429171" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Occurrence and effect of lower extremity ulcer in rheumatoid arthritis -- a population-based Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18176994" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Clustering of extraarticular manifestations in patients with rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17544962" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Rheumatoid nodule.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5727884" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Pulmonary lesions and rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3873887" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Lung biopsy in rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12860726" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22703938" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Heart involvement in rheumatoid arthritis: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10399790" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Echocardiographic findings and 24-h electrocardiographic Holter monitoring in patients with nodular and non-nodular rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2441708" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Macrophage migration and maturation within rheumatoid nodules.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2968782" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Immunohistology of rheumatoid nodules and rheumatoid synovium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2784661" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Immunological and immunohistochemical analysis of rheumatoid nodules.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9778219" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Pathogenic mechanisms in the rheumatoid nodule: comparison of proinflammatory cytokine production and cell adhesion molecule expression in rheumatoid nodules and synovial membranes from the same patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17204487" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Pulmonary rheumatoid nodules demonstrating features usually associated with rheumatoid synovial membrane.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16447242" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Morphologic and quantitative assessment of CD20+ B cell infiltrates in rheumatoid arthritis-associated nonspecific interstitial pneumonia and usual interstitial pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4342958" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : A collagenolytic system produced by primary cultures of rheumatoid nodule tissue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12571841" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Cytokine profile of the rheumatoid nodule suggests that it is a Th1 granuloma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7504437" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Palisading cells of rheumatoid nodules: comparison with synovial intimal cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9797554" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : A comparative phenotypical analysis of rheumatoid nodules and rheumatoid synovium with special reference to adhesion molecules and activation markers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18512780" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Different T cell subsets in the nodule and synovial membrane: absence of interleukin-17A in rheumatoid nodules.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10955322" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Complement mediated vascular endothelial injury in rheumatoid nodules: a histopathological and immunohistochemical study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27765067" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Rheumatoid arthritis antigens homocitrulline and citrulline are generated by local myeloperoxidase and peptidyl arginine deiminases 2, 3 and 4 in rheumatoid nodule and synovial tissue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23536012" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15022316" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Lack of association of the HLA-DRB1 shared epitope with rheumatoid nodules: an individual patient data meta-analysis of 3,272 Caucasian patients with rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15529352" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20444266" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Association of IL4R single-nucleotide polymorphisms with rheumatoid nodules in African Americans with rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34248985" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : In Rheumatoid Arthritis Patients, HLA-DRB1*04:01 and Rheumatoid Nodules Are Associated With ACPA to a Particular Fibrin Epitope.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2006182" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3741499" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9214432" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7346969" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Smoking and rheumatoid vasculitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16947780" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19213849" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : High disease activity disability burden and smoking predict severe extra-articular manifestations in early rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12969349" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Vocal fold deposits in autoimmune disease--an unusual cause of hoarseness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3713605" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Pleuropulmonary necrobiotic rheumatoid nodules. A review and clinicopathological study of six patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22504557" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: findings in 10 patients from the French AutoImmunity and Rituximab/Rheumatoid Arthritis registry (AIR/PR registry).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11358070" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Cardiac involvement in rheumatoid disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6882034" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Complete heart block in rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10519677" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Unusual cause of a stroke in a patient with seronegative rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9044084" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : A rare case of embolizing cardiac tumor: rheumatoid nodule of the mitral valve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15124265" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Embolic complications of a mitral valve rheumatoid nodule.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25037187" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Rheumatoid nodule in the lower lip of a patient with rheumatoid arthritis: a novel case report and review of literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27618678" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Rheumatoid nodule presenting as a buccal submucosal nodule: A rare presentation of a common disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31133043" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Rheumatoid nodules in thyroid gland parenchyma as an expression of rheumatoid arthritis: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23645652" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : A rheumatoid nodule in an unusual location: mediastinal lymph node.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31356396" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Multiple Rheumatoid Nodules Mimicking Widespread Metastases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3804218" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Rheumatoid nodules in liver.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30194686" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : A Large Rheumatoid Nodule Mimicking Hepatic Malignancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2327849" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Multiple rheumatoid nodules of the renal cortex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12222551" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : A review of methotrexate-induced accelerated nodulosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11470988" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : The HLA-DRB1*0401 allele and the development of methotrexate-induced accelerated rheumatoid nodulosis: a follow-up study of 79 Caucasian patients with rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29859543" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27846189" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : The plausible association of MTHFR and ADORA2A polymorphisms with nodules in rheumatoid arthritis patients treated with methotrexate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18385217" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Management of accelerated pulmonary nodulosis following etanercept therapy in a patient with rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18392955" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Intrapulmonary rheumatoid nodules in a patient with long-standing rheumatoid arthritis treated with leflunomide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16211338" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Rheumatoid lung nodulosis and osteopathy associated with leflunomide therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26177173" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Methotrexate-induced Accelerated Pulmonary Nodulosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3058975" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Rheumatoid nodulosis: report of two new cases and discussion of diagnostic criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17041479" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Rheumatoid nodulosis: is it a different subset of rheumatoid arthritis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1078777" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Rheumatoid nodulosis: an unusual variant of rheumatoid disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1424263" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Systemic lupus erythematosus presenting with 'rheumatoid nodules'.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12814768" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Rheumatoid nodules in systemic lupus erythematosus: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1153250" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Benign rheumatoid nodules.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3389901" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Subcutaneous rheumatoid nodules.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2661569" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : The subcutaneous rheumatoid nodule.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30288558" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Rheumatoid pulmonary nodules: clinical and imaging features compared with malignancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32621699" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Pseudorheumatoid nodule: a variant of granuloma annulare?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36991243" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Rheumatoid nodules: a narrative review of histopathological progression and diagnostic consideration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23329684" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Rituximab as effective treatment in a case of severe subcutaneous nodulosis in rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21906436" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Efficacy of rituximab on pulmonary nodulosis occurring or increasing in patients with rheumatoid arthritis during anti-TNF-αtherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22328566" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Marked improvement of lung rheumatoid nodules after treatment with tocilizumab.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30212893" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Tomographic regression of pulmonary rheumatoid nodules under baricitinib therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37740125" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Rheumatoid arthritis with pulmonary accelerated rheumatoid nodules treated by baricitinib: a case-based review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1450803" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Injection therapy of superficial rheumatoid nodules.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16163443" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Corticosteroid injections reduce size of rheumatoid nodules.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26864307" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Patient rated outcomes study into the surgical interventions available for the rheumatoid hand and wrist.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
